An interventional study of Dexmedetomidine and Saline in Pressor Response, sponsored by Assiut University. Not yet recruiting. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-09-10.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
Dexmedetomidine nebulization in sever preeclamptic patients
Dexmedetomidine nebulization for attenuation of pressor response to laryngoscopy and endotracheal intubation in sever preeclamptic patients undergoing caesarean section under general anaesthesia. A prospective randomized clinical trial.
883 studies on the registry are indexed under Pre-Eclampsia; 238 are open to participants now.
This study's planned enrollment of 100 is close to the median of 110 across 468 interventional studies indexed under Pre-Eclampsia.
Browse Pre-Eclampsia studies →Assiut University is the lead sponsor of 4,916 studies on the registry; 2,113 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Nebulization of dexmedetomidine
Drug: Dexmedetomidine
Nebulization of saline
Drug: Saline
Nebulization of dexmedetomidine
Nebulization of normal saline
Systolic blood pressure in response to endotracheal intubation
the change in systolic blood pressure in response to endotracheal intubation
Time frame: Intraoperative
Optic nerve sheath diameter
the change in optic nerve sheath diameter in response to endotracheal intubation
Time frame: Intraoperative
Incidence of maternal postoperative sore throat
Time frame: 1 hour Postoperative
Incidence of maternal postoperative hoarseness of voice
Time frame: 1 hour Postoperative
No study locations are listed for this record.
This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University